Morgan Keegan Lowers PT on Haemonetics To $65

Morgan Keegan has lowered the price target on Haemonetics Corporation HAE from $76 to $65 and maintains its Market Perform rating.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Price TargetAnalyst RatingsHealth CareHealth Care SuppliesMorgan Keegan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!